Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation

Autor: Rasmus Heje Thomsen, Jette Sønderskov Gørløv, Søren Ramme Nielsen, Charlotte Madsen, Susanne Oksbjerg Dalton, Kristina Fruerlund Nielsen, Peter de Nully Brown, Maja Halgren Olsen, Bente Arboe, Anne Katrine Duun-Henriksen

Publikováno v: Arboe, B, Halgren Olsen, M, Duun-Henriksen, A K, Gørløv, J S, Nielsen, K F, Thomsen, R H, Madsen, C, Ramme Nielsen, S, Dalton, S O & Brown, P D N 2018, ' Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation ', Leukemia and Lymphoma, vol. 59, no. 5, pp. 1153-1162 . https://doi.org/10.1080/10428194.2017.1369061
Arboe, B, Halgren Olsen, M, Duun-Henriksen, A K, Gørløv, J S, Nielsen, K F, Thomsen, R H, Madsen, C, Nielsen, S R, Dalton, S O & Brown, P D N 2018, ' Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation ', Leukemia and Lymphoma, vol. 59, no. 5, pp. 1153-1162 . https://doi.org/10.1080/10428194.2017.1369061

In patients with relapsed diffuse large B-cell lymphoma (DLBCL), high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is standard treatment. Here, we aim to identify factors associated with survival in patients undergoing AS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1740139ca7428f6006413c145c81abc
https://portal.findresearcher.sdu.dk/da/publications/1af97bf7-5eb6-4557-a706-f2b00777ae55

Prognostic Factors for Patients with Diffuse Large B Cell Lymphoma and Transformed Indolent Lymphoma Undergoing Autologous Stem Cell Transplantation in Denmark 2000-2012

Autor: Peter de Nully Brown, Charlotte Madsen, Kristina Fruerlund Nielsen, Rasmus Heje Thomsen, Bente Arboe, Jette Soenderskov Goerloev, Soeren Ramme Nielsen

Publikováno v: Arboe, B, Fruerlund Nielsen, K, Madsen, C, Thomsen, R H, Ramme Nielsen, S, Gørløv, J S & de Nully Brown, P 2015, ' Prognostic Factors for Patients with Diffuse Large B Cell Lymphoma and Transformed Indolent Lymphoma Undergoing Autologous Stem Cell Transplantation in Denmark 2000-2012 ', Blood, vol. 126, no. 23, pp. 1983 . < http://www.bloodjournal.org/content/126/23/1983 >

Introduction: Diffuse large B-cell lymphoma (DLBCL) is the largest subgroup of malignant lymphoma. Today more than 80% of the patients will achieve partial or complete remission. However more than 20 % will either relapse or present with refractory d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9689b843aafe134ca86692374d6fad19
https://vbn.aau.dk/da/publications/f8446c0e-0e9c-4c97-9cec-c75976ad0e33

Low Dose of Nonselective B Blockers may Reduce Risk of Death in Patients with Cirrhosis after an Episode of Spontaneous Bacterial Peritonitis

Autor: Kristina Fruerlund Nielsen, Annette Dam Fialla, Aleksander Krag, Bjørn Stæhr Madsen

Publikováno v: Journal of Hepatology. 64:S654-S655

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b59a63c92fa006b3eef0ee32d921e060
https://doi.org/10.1016/s0168-8278(16)01226-5